Medical Communications

GlaxoSmithKline has announced that it is to slash half of its workforce at its site in Ulverston, UK, as part …

As September came to a close and October began the UK was hit hard in the headlines after American firm …

The FDA has chosen to expand the label of Roche’s Hemlibra (emicizumab-kxwh), approving it for routine prophylaxis to prevent the …

Gilead’s CAR T therapy Yescarta is set to be made available on the NHS in England for adults with aggressive …

The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would …

Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …

Nick Stephens of The RSA Group discusses the importance of stopping to quantify the effectiveness of board members within life …

A new group, organised under the banner of the Alliance to Protect Medical Innovation, is blaming hospitals and PBM’s for …

Male doctors in the United Kingdom earn 56% more than their female counterparts, according to a survey conducted by Medscape. …

In light of continued austerity gripping the NHS, it was uplifting to hear in July that the health service had …

French pharma firm Ipsen has announced the appointment of Dr. Yan Moore as Senior Vice President, Head of Oncology Therapeutic …

Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …

Swiss multinational Novartis have paired up with Chinese drugmaker Cellular Biomedicine (CBMG) in order to manufacture CAR-T therapy Kymriah in …

Gilead has announced its intention to undercut itself by releasing generic versions of its blockbuster drugs for the treatment of …

The British government has been accused of using Brexit to avoid implementing new EU legislation preventing powerful antibiotics from be …